Search

We have investigated the sensitivity to oncogenic transformation by an origin-defective SV40-containing plasmid, '8-16' (ori-SV40), of skin fibroblasts from normal individuals (NF), and from patients with 2 hereditary diseases characterized by an increased cancer risk, Bloom's syndrome (BS) and Fanconi's anemia (FA). It was hypothesized that perhaps these cells had already undergone some stage, or stages, of the progression to neoplasia, and that as a consequence of these changes, one could observe differential expression of characteristics of the transformed phenotype in these cells compared to normal, or perhaps they would behave differently in vivo. The data showed that FA cells and NF possessed comparable sensitivities to transformation by ori-SV40 DNA transfection, as measured either by focus formation above a confluent monolayer, or anchorage-independent growth. The BS cells, on the other hand, were 5-10 times less sensitive to this method of transformation, and further, the transformed phenotype was unstable. The resistance of BS cells to transformation by the 8-16 plasmid may be a reflection of their inherent genetic instability which affects stable integration and expression of the transfected plasmid DNA, since no differences in initial uptake of transfected DNA were observed between the various cell strains. Immortality and tumorigenicity were not readily demonstrated in this ori-SV40 transformation model. The results are discussed in relationship to the characteristics of the transformed phenotype of chemically treated normal human fibroblasts. SV40, an agent known to transform human cells, can be cast in a positive control role with respect to the appropriateness of the assays, the frequency of appearance of various markers, immortality and tumorigenicity. The tumorigenicity results are further compared to results obtained during the establishment of a wide range of fresh human tumor biopsies as xenograft lines in athymic nude mice, with particular emphasis on the sarcoma data.

Four Bloom's syndrome fibroblast strains were examined for chromosome changes, immortalization, tumorigenicity, anchorage independent growth, and the ability to grow in low serum. Only one strain (GM 1492) exhibited some of these characteristics, which are generally associated with neoplastic cells. Strain GM 1492 also exhibited a low frequency of cells that contained double minute chromosomes. Substrains from GM 1492 were cloned, and showed that some of the above characteristics were expressed as a heritable trait. Karyotype instability (heteroploidy) was seen in all clones studied, with modal chromosome numbers ranging from near-diploid to near-tetraploid, as confirmed by DNA content distributions. Although no clones studied were tumorigenic in nude mice or immortalized, some showed an increased cellular proliferative capacity. Several clones were isolated after growth in 1% fetal bovine serum, and these all showed an increased expression of double minute chromosomes. Two of these 1% serum-isolated clones, (1492/clone 3-1% and clone 8-1%) were further studied by G-banding analysis, and found to show specific chromosomal anomalies. Clone 3 showed monosomy for chromosomes #4, #13, and #19, along with the absence of both copies of chromosome #7 but with both i(7p) and i(7q) chromosomes consistently seen. Clone 8 showed monosomy for chromosome #13. Preliminary experiments using DNA slot blots indicated that erb a and b, v-fes, v-mos, c-myc, n-myc, v-src, and v-sis showed no sequence amplification in GM 1492 cells or subclones.

Bloom's syndrome (BS) and EM9 cells both display elevated frequencies of sister chromatid exchange (SCE) following growth for two rounds of DNA replication in bromodeoxyuridine (BrdU)-containing medium. To learn whether hyperresponsiveness to BrdU itself might play a role in causing the SCE elevation, the effects of BrdU on two other parameters, cellular proliferation and chromosome disruption, were examined, comparing the responses of BS and normal lymphoblastoid cells and of EM9 and CHO cells. BS and normal cells responded similarly with respect to growth for 4 days in BrdU-containing medium (0, 1, 3, and 5 micrograms/ml). Chromosome aberrations were increased only slightly in the BS and normal cells after 2 days in BrdU. CHO cells responded to growth in BrdU-containing medium like BS and normal cells; however, little growth of EM9 was detected at any of the BrdU concentrations employed. CHO and EM9 cells also exhibited strikingly different amounts of chromosome damage following growth in BrdU. After 2 days in 1, 3, and 5 micrograms/ml BrdU 21%, 46%, and 50%, respectively, of the CHO cells had chromosome aberrations in contrast to 92%, 96%, and 98% of the EM9 cells. Most of the aberrations in the BrdU-treated CHO cells consisted of what appeared to be polycentric and ring chromosomes or chromosomes exhibiting telemere association. Acentric fragments were absent from most cells with polycentric and ring chromosomes, indicating either that the abnormal chromosomes were formed during an earlier cell cycle or that the abnormal chromosomes represent a form of association in which the telomeres are apposed so tightly that the juncture between chromosomes cannot be identified microscopically.(ABSTRACT TRUNCATED AT 250 WORDS)